Sunday, June 23, 2024
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Behavioural Neurologist and Medical Director
Toronto Memory Program
Toronto, Canada
Professor of Neurology
Lund University
Lund, Sweden
Professor in Neurochemistry
Amsterdam UMC
Amsterdam, the Netherlands
Stanford, California, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™
This activity is intended for neurologists, geriatricians, geriatric psychiatrists, memory specialists, nurse practitioners, and physician assistants.
The goal of this activity is for learners to be better able to understand recent advances in biomarkers and gain experience on how they can utilize cognitive assessment tools and advanced diagnostics for early diagnosis of Alzheimer’s disease (AD).
Upon completion of this activity, participants will be able to:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Behavioural Neurologist and Medical Director
Toronto Memory Program
Toronto, Canada
Professor of Neurology
Lund University
Lund, Sweden
Professor in Neurochemistry
Amsterdam UMC
Amsterdam, the Netherlands
Stanford, California, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 3/29/2024
Valid for credit through: 3/29/2025, 11:59 PM EST
processing....
Download the pdf.
| « Return to: Navigating Alzheimer’s Disease Diagnosis and Biomarkers: Making an IMPACT Through a Medical Simulation Challenge |
